Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial - Concepedia

Concepedia

Publication | Closed Access

Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial

42

Citations

0

References

2009

Year

Trino Baptista, Nairy Rangel, Yamily El Fakih, Euderruh Uzcátegui, Tatiana Galeazzi, Serge Beaulieu, Enma Araujo de Baptista

Pharmacopsychiatry

Abstract

The positive impact of rosiglitazone was limited to improved glycemic control. It cannot be recommended for metabolic control during olanzapine treatment.